224 related articles for article (PubMed ID: 20361951)
21. Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry.
Schaub S; Wilkins J; Weiler T; Sangster K; Rush D; Nickerson P
Kidney Int; 2004 Jan; 65(1):323-32. PubMed ID: 14675066
[TBL] [Abstract][Full Text] [Related]
22. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
[TBL] [Abstract][Full Text] [Related]
23. Reliability of human serum protein profiles generated with C8 magnetic beads assisted MALDI-TOF mass spectrometry.
de Noo ME; Tollenaar RA; Ozalp A; Kuppen PJ; Bladergroen MR; Eilers PH; Deelder AM
Anal Chem; 2005 Nov; 77(22):7232-41. PubMed ID: 16285670
[TBL] [Abstract][Full Text] [Related]
24. Identification of the SELDI ProteinChip human serum retentate by microcapillary liquid chromatography-tandem mass spectrometry.
Zhou M; Prieto DA; Lucas DA; Chan KC; Issaq HJ; Veenstra TD; Conrads TP
J Proteome Res; 2006 Sep; 5(9):2207-16. PubMed ID: 16944932
[TBL] [Abstract][Full Text] [Related]
25. The potential biomarkers for thromboembolism detected by SELDI-TOF-MS.
Hong M; Zhang X; Hu Y; Wang H; He W; Mei H; Yu J; Guo T; Song S
Thromb Res; 2009; 123(3):556-64. PubMed ID: 18620739
[TBL] [Abstract][Full Text] [Related]
26. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
27. A magnetic bead-based serum proteomic fingerprinting method for parallel analytical analysis and micropreparative purification.
Wong MY; Yu KO; Poon TC; Ang IL; Law MK; Chan KY; Ng EW; Ngai SM; Sung JJ; Chan HL
Electrophoresis; 2010 May; 31(10):1721-30. PubMed ID: 20414880
[TBL] [Abstract][Full Text] [Related]
28. Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOF.
Gretzer MB; Chan DW; van Rootselaar CL; Rosenzweig JM; Dalrymple S; Mangold LA; Partin AW; Veltri RW
Prostate; 2004 Sep; 60(4):325-31. PubMed ID: 15264244
[TBL] [Abstract][Full Text] [Related]
29. Protein profiling of post-prostatic massage urine specimens by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to discriminate between prostate cancer and benign lesions.
Okamoto A; Yamamoto H; Imai A; Hatakeyama S; Iwabuchi I; Yoneyama T; Hashimoto Y; Koie T; Kamimura N; Mori K; Yamaya K; Ohyama C
Oncol Rep; 2009 Jan; 21(1):73-9. PubMed ID: 19082445
[TBL] [Abstract][Full Text] [Related]
30. Fractional factorial design for optimization of the SELDI protocol for human adipose tissue culture media.
Szalowska E; van Hijum SA; Roelofsen H; Hoek A; Vonk RJ; te Meerman GJ
Biotechnol Prog; 2007; 23(1):217-24. PubMed ID: 17269691
[TBL] [Abstract][Full Text] [Related]
31. Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles.
Calvano CD; Aresta A; Iacovone M; De Benedetto GE; Zambonin CG; Battaglia M; Ditonno P; Rutigliano M; Bettocchi C
J Pharm Biomed Anal; 2010 Mar; 51(4):907-14. PubMed ID: 19939598
[TBL] [Abstract][Full Text] [Related]
32. Comparison between the matrices alpha-cyano-4-hydroxycinnamic acid and 4-chloro-alpha-cyanocinnamic acid for trypsin, chymotrypsin, and pepsin digestions by MALDI-TOF mass spectrometry.
Jaskolla TW; Papasotiriou DG; Karas M
J Proteome Res; 2009 Jul; 8(7):3588-97. PubMed ID: 19435303
[TBL] [Abstract][Full Text] [Related]
33. A proteomic (SELDI-TOF-MS) approach to estrogen agonist screening.
Walker CC; Salinas KA; Harris PS; Wilkinson SS; Watts JD; Hemmer MJ
Toxicol Sci; 2007 Jan; 95(1):74-81. PubMed ID: 16917070
[TBL] [Abstract][Full Text] [Related]
34. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.
de Seny D; Fillet M; Meuwis MA; Geurts P; Lutteri L; Ribbens C; Bours V; Wehenkel L; Piette J; Malaise M; Merville MP
Arthritis Rheum; 2005 Dec; 52(12):3801-12. PubMed ID: 16320331
[TBL] [Abstract][Full Text] [Related]
35. Profiling of urine using ProteinChip® technology.
Woodbury RL; McCarthy DL; Bulman AL
Methods Mol Biol; 2012; 818():97-107. PubMed ID: 22083818
[TBL] [Abstract][Full Text] [Related]
36. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
37. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
38. A review of experimental design best practices for proteomics based biomarker discovery: focus on SELDI-TOF.
Caffrey RE
Methods Mol Biol; 2010; 641():167-83. PubMed ID: 20407947
[TBL] [Abstract][Full Text] [Related]
39. The use of laser microdissection and SELDI-TOF MS in ovarian cancer tissue to identify protein profiles.
Cadron I; Van Gorp T; Amant F; Vergote I; Moerman P; Waelkens E; Daemen A; Van De Plas R; De Moor B; Zeillinger R
Anticancer Res; 2009 Apr; 29(4):1039-45. PubMed ID: 19414343
[TBL] [Abstract][Full Text] [Related]
40. [Detection of differentially expressed proteins in the semen of oligospermia patients by SELDI-TOF-MS technology].
Liu CB; Liang Y; Pan CQ; Zhang J
Zhonghua Nan Ke Xue; 2009 Mar; 15(3):232-6. PubMed ID: 19452695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
